Tarah Noel Gibbs, NP | |
2655 Warrenville Rd, Downers Grove, IL 60515-5555 | |
(866) 949-0108 | |
Not Available |
Full Name | Tarah Noel Gibbs |
---|---|
Gender | Female |
Speciality | Nurse Practitioner - Family |
Location | 2655 Warrenville Rd, Downers Grove, Illinois |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1114472610 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363LF0000X | Nurse Practitioner - Family | 209014725 (Illinois) | Secondary |
363LF0000X | Nurse Practitioner - Family | 277000407 (Illinois) | Primary |
Entity Name | Proctor Health Systems |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1134173917 PECOS PAC ID: 3476440173 Enrollment ID: O20040227000906 |
News Archive
New research suggests that smoking is more common in the gay community than in the general population, but scientists are calling for more research to document this difference.
Data from the first COVID-19 patients treated at three large Massachusetts hospitals reveal important trends, including disproportionate representation of vulnerable populations, high rates of disease-related complications, and the need for post-discharge, post-acute care and monitoring.
ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today announced in vitro study results showing that a wound dressing containing ionic silver is able to kill several strains of multidrug-resistant organisms (MDROs), commonly referred to as 'superbugs.' The study results were published in the August issue of the International Wound Journal.
Schering-Plough Corporation, (NYSE: SGP), today announced that the European Medicines Agency (EMEA) has validated (accepted for review) the company's Marketing Authorization Application (MAA) for a fixed-dose combination of mometasone furoate and formoterol fumarate for the maintenance treatment of asthma in patients 12 years of age and older.
Scientists at Stanford and Harvard Universities collaborated to assess the clinical usefulness of analyzing a patient's full genome for disease risks and unusual drug responses. The work brings closer to reality the concept that whole-genome sequencing might one day play a clinical role.
› Verified 9 days ago
Entity Name | Belcrest Services Ltd |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1245275312 PECOS PAC ID: 9335037217 Enrollment ID: O20040310001103 |
News Archive
New research suggests that smoking is more common in the gay community than in the general population, but scientists are calling for more research to document this difference.
Data from the first COVID-19 patients treated at three large Massachusetts hospitals reveal important trends, including disproportionate representation of vulnerable populations, high rates of disease-related complications, and the need for post-discharge, post-acute care and monitoring.
ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today announced in vitro study results showing that a wound dressing containing ionic silver is able to kill several strains of multidrug-resistant organisms (MDROs), commonly referred to as 'superbugs.' The study results were published in the August issue of the International Wound Journal.
Schering-Plough Corporation, (NYSE: SGP), today announced that the European Medicines Agency (EMEA) has validated (accepted for review) the company's Marketing Authorization Application (MAA) for a fixed-dose combination of mometasone furoate and formoterol fumarate for the maintenance treatment of asthma in patients 12 years of age and older.
Scientists at Stanford and Harvard Universities collaborated to assess the clinical usefulness of analyzing a patient's full genome for disease risks and unusual drug responses. The work brings closer to reality the concept that whole-genome sequencing might one day play a clinical role.
› Verified 9 days ago
Entity Name | Methodist Medical Center Of Illinois |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1184670663 PECOS PAC ID: 1355259714 Enrollment ID: O20040315000196 |
News Archive
New research suggests that smoking is more common in the gay community than in the general population, but scientists are calling for more research to document this difference.
Data from the first COVID-19 patients treated at three large Massachusetts hospitals reveal important trends, including disproportionate representation of vulnerable populations, high rates of disease-related complications, and the need for post-discharge, post-acute care and monitoring.
ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today announced in vitro study results showing that a wound dressing containing ionic silver is able to kill several strains of multidrug-resistant organisms (MDROs), commonly referred to as 'superbugs.' The study results were published in the August issue of the International Wound Journal.
Schering-Plough Corporation, (NYSE: SGP), today announced that the European Medicines Agency (EMEA) has validated (accepted for review) the company's Marketing Authorization Application (MAA) for a fixed-dose combination of mometasone furoate and formoterol fumarate for the maintenance treatment of asthma in patients 12 years of age and older.
Scientists at Stanford and Harvard Universities collaborated to assess the clinical usefulness of analyzing a patient's full genome for disease risks and unusual drug responses. The work brings closer to reality the concept that whole-genome sequencing might one day play a clinical role.
› Verified 9 days ago
Entity Name | In Home Medical Group Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1497087175 PECOS PAC ID: 3779612395 Enrollment ID: O20100520000116 |
News Archive
New research suggests that smoking is more common in the gay community than in the general population, but scientists are calling for more research to document this difference.
Data from the first COVID-19 patients treated at three large Massachusetts hospitals reveal important trends, including disproportionate representation of vulnerable populations, high rates of disease-related complications, and the need for post-discharge, post-acute care and monitoring.
ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today announced in vitro study results showing that a wound dressing containing ionic silver is able to kill several strains of multidrug-resistant organisms (MDROs), commonly referred to as 'superbugs.' The study results were published in the August issue of the International Wound Journal.
Schering-Plough Corporation, (NYSE: SGP), today announced that the European Medicines Agency (EMEA) has validated (accepted for review) the company's Marketing Authorization Application (MAA) for a fixed-dose combination of mometasone furoate and formoterol fumarate for the maintenance treatment of asthma in patients 12 years of age and older.
Scientists at Stanford and Harvard Universities collaborated to assess the clinical usefulness of analyzing a patient's full genome for disease risks and unusual drug responses. The work brings closer to reality the concept that whole-genome sequencing might one day play a clinical role.
› Verified 9 days ago
Entity Name | Perspective Behavioral And Pain Solutions Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1326671702 PECOS PAC ID: 1951732106 Enrollment ID: O20200504001274 |
News Archive
New research suggests that smoking is more common in the gay community than in the general population, but scientists are calling for more research to document this difference.
Data from the first COVID-19 patients treated at three large Massachusetts hospitals reveal important trends, including disproportionate representation of vulnerable populations, high rates of disease-related complications, and the need for post-discharge, post-acute care and monitoring.
ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today announced in vitro study results showing that a wound dressing containing ionic silver is able to kill several strains of multidrug-resistant organisms (MDROs), commonly referred to as 'superbugs.' The study results were published in the August issue of the International Wound Journal.
Schering-Plough Corporation, (NYSE: SGP), today announced that the European Medicines Agency (EMEA) has validated (accepted for review) the company's Marketing Authorization Application (MAA) for a fixed-dose combination of mometasone furoate and formoterol fumarate for the maintenance treatment of asthma in patients 12 years of age and older.
Scientists at Stanford and Harvard Universities collaborated to assess the clinical usefulness of analyzing a patient's full genome for disease risks and unusual drug responses. The work brings closer to reality the concept that whole-genome sequencing might one day play a clinical role.
› Verified 9 days ago
Entity Name | Applebaum Physiatry Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1700598059 PECOS PAC ID: 8729453436 Enrollment ID: O20230412000147 |
News Archive
New research suggests that smoking is more common in the gay community than in the general population, but scientists are calling for more research to document this difference.
Data from the first COVID-19 patients treated at three large Massachusetts hospitals reveal important trends, including disproportionate representation of vulnerable populations, high rates of disease-related complications, and the need for post-discharge, post-acute care and monitoring.
ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today announced in vitro study results showing that a wound dressing containing ionic silver is able to kill several strains of multidrug-resistant organisms (MDROs), commonly referred to as 'superbugs.' The study results were published in the August issue of the International Wound Journal.
Schering-Plough Corporation, (NYSE: SGP), today announced that the European Medicines Agency (EMEA) has validated (accepted for review) the company's Marketing Authorization Application (MAA) for a fixed-dose combination of mometasone furoate and formoterol fumarate for the maintenance treatment of asthma in patients 12 years of age and older.
Scientists at Stanford and Harvard Universities collaborated to assess the clinical usefulness of analyzing a patient's full genome for disease risks and unusual drug responses. The work brings closer to reality the concept that whole-genome sequencing might one day play a clinical role.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Tarah Noel Gibbs, NP 1 Westbrook Corporate Ctr, Ste 300, Westchester, IL 60154-5709 Ph: (866) 949-0108 | Tarah Noel Gibbs, NP 2655 Warrenville Rd, Downers Grove, IL 60515-5555 Ph: (866) 949-0108 |
News Archive
New research suggests that smoking is more common in the gay community than in the general population, but scientists are calling for more research to document this difference.
Data from the first COVID-19 patients treated at three large Massachusetts hospitals reveal important trends, including disproportionate representation of vulnerable populations, high rates of disease-related complications, and the need for post-discharge, post-acute care and monitoring.
ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today announced in vitro study results showing that a wound dressing containing ionic silver is able to kill several strains of multidrug-resistant organisms (MDROs), commonly referred to as 'superbugs.' The study results were published in the August issue of the International Wound Journal.
Schering-Plough Corporation, (NYSE: SGP), today announced that the European Medicines Agency (EMEA) has validated (accepted for review) the company's Marketing Authorization Application (MAA) for a fixed-dose combination of mometasone furoate and formoterol fumarate for the maintenance treatment of asthma in patients 12 years of age and older.
Scientists at Stanford and Harvard Universities collaborated to assess the clinical usefulness of analyzing a patient's full genome for disease risks and unusual drug responses. The work brings closer to reality the concept that whole-genome sequencing might one day play a clinical role.
› Verified 9 days ago
Theresa Dolan, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1441 Branding Ave Ste 310, Downers Grove, IL 60515 Phone: 630-829-1038 Fax: 630-829-1080 | |
Mrs. Tamyra Michelle Janicki, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1315 Butterfield Rd Ste 206, Downers Grove, IL 60515 Phone: 630-317-7690 Fax: 630-317-7894 | |
Mrs. Ebonique Thomson, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3005 Highland Pkwy, Downers Grove, IL 60515 Phone: 716-249-1820 | |
Mansi P Patel, ACNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1441 Branding Ave, Ste 310, Downers Grove, IL 60515 Phone: 312-609-0300 | |
Ms. Elizabeth Sowa, MSN, ANP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1441 Branding Ave Ste 310, Downers Grove, IL 60515 Phone: 630-829-1084 | |
Letasha Lewis, MSN, FNP-C Nurse Practitioner Medicare: May Accept Medicare Assignments Practice Location: 900 Ogden Ave # 335, Downers Grove, IL 60515 Phone: 773-234-0388 Fax: 773-234-0394 | |
Lizeht Monarrez, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1441 Branding Ave Ste 310, Downers Grove, IL 60515 Phone: 630-829-1084 |